News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2024
August 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Jennifer Buell: NCI Announces Availability of Botensilimab for Clinical Development
Jul 8, 2024, 12:29

Jennifer Buell: NCI Announces Availability of Botensilimab for Clinical Development

Jennifer Buell, President and Chief Executive Officer of MiNK Therapeutics, shared on X:

“NCI Announces Availability of Botensilimab for Clinical Development

Botensilimab is available through the NCI CTEP program in collaboration with Agenus. Strong LOIs for clinical studies are being evaluated.”

Read further.
Source: Jennifer Buell/X

Agenus Biotechnology botensilimab cancer Cancer research Clinical Development clinical studies drug development immunotherapy Jennifer Buell LOI MiNK Therapeutics NCI NCI CTEP program OncoDaily Oncology pharmaceutical collaboration
Blog
Aug 29, 2024, 17:20
Apply for ESO’s Certificate of Advanced Studies in Lung Cancer
Blog
Aug 29, 2024, 17:19
EU Navigate helps implement interventions for older people with cancer and their caregivers across Europe - European Cancer Organisation
Blog
Aug 29, 2024, 17:16
Day in the Life of a Leukaemia PhD researcher - Manchester Cancer Research Centre
Blog
Aug 29, 2024, 17:12
Haemato-oncology highlights from EHA2024 Congress - Sharing Progress in Cancer Care
Insight
Aug 29, 2024, 17:06
ESMO announces Tumour-Agnostic Classifier and Screener in Annals of Oncology
Insight
Aug 29, 2024, 17:03
Effects of the bone ecosystem on metastatic Prostate Cancer evolution and treatment response - NCI Physical Sciences
Career
Aug 29, 2024, 17:03
Suzanne Birdsey: Opportunity for a Senior Strategy Manager at CRUK
Insight
Aug 29, 2024, 17:01
Elad Sharon: Quite promising for c-MET over-expressing NSCLC
Insight
Aug 29, 2024, 16:59
Talha Badar: Overview of AML induction strategies
Insight
Aug 29, 2024, 16:56
Stephen Liu: Overview of outcomes with 1L osimertinib
Blog
Aug 29, 2024, 16:54
Robin Zon: the second installment of the President’s Corner with Professor Sabe Sabesan
Insight
Aug 29, 2024, 16:53
Dario Trapani: Very informative story on how clinical trials have been so far "tolerated" in their design